Cite
HARVARD Citation
Carnevalli, L. et al. (2018). PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. Journal for immunotherapy of cancer. 6 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carnevalli, L. et al. (2018). PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. Journal for immunotherapy of cancer. 6 (1), p. . [Online].